Aignostics launches four research-use HETA Clinical pathology AI tools
Source publication date
Site published
Announced October 16, the products are HETA Quality Control, Tumor Detect, Mitosis and Tumor Cellularity. They analyze whole-slide H&E images using the HETA platform, formerly Atlas H&E-TME.
Summary
The new suite analyzes slide quality, tumor regions, mitoses and tumor-cell content.
Editorial view
Editorial view: a general tissue-analysis platform is becoming task-specific laboratory software. Evaluation should consider measured workflow performance and permitted use.
Evidence and limitations
The manufacturer specifies research use only, excluding diagnostic procedures. The name 'Clinical' does not establish diagnostic authorization or proven clinical benefit.